rs3187907
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001101648.2(NPC1L1):c.*837A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 152,442 control chromosomes in the GnomAD database, including 1,913 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1910 hom., cov: 33)
Exomes 𝑓: 0.17 ( 3 hom. )
Consequence
NPC1L1
NM_001101648.2 3_prime_UTR
NM_001101648.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.444
Publications
10 publications found
Genes affected
NPC1L1 (HGNC:7898): (NPC1 like intracellular cholesterol transporter 1) The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1L1 | NM_001101648.2 | c.*837A>G | 3_prime_UTR_variant | Exon 19 of 19 | ENST00000381160.8 | NP_001095118.1 | ||
NPC1L1 | NM_013389.3 | c.*837A>G | 3_prime_UTR_variant | Exon 20 of 20 | NP_037521.2 | |||
NPC1L1 | XM_011515326.4 | c.*837A>G | 3_prime_UTR_variant | Exon 18 of 18 | XP_011513628.1 | |||
NPC1L1 | XM_011515328.3 | c.*837A>G | 3_prime_UTR_variant | Exon 16 of 16 | XP_011513630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1L1 | ENST00000381160.8 | c.*837A>G | 3_prime_UTR_variant | Exon 19 of 19 | 1 | NM_001101648.2 | ENSP00000370552.3 | |||
NPC1L1 | ENST00000289547.8 | c.*837A>G | 3_prime_UTR_variant | Exon 20 of 20 | 1 | ENSP00000289547.4 | ||||
NPC1L1 | ENST00000546276.5 | c.*837A>G | 3_prime_UTR_variant | Exon 18 of 18 | 1 | ENSP00000438033.1 |
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21119AN: 152168Hom.: 1910 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
21119
AN:
152168
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.167 AC: 26AN: 156Hom.: 3 Cov.: 0 AF XY: 0.170 AC XY: 15AN XY: 88 show subpopulations
GnomAD4 exome
AF:
AC:
26
AN:
156
Hom.:
Cov.:
0
AF XY:
AC XY:
15
AN XY:
88
show subpopulations
African (AFR)
AF:
AC:
0
AN:
4
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
0
AN:
4
European-Finnish (FIN)
AF:
AC:
1
AN:
6
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
22
AN:
134
Other (OTH)
AF:
AC:
3
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.139 AC: 21115AN: 152286Hom.: 1910 Cov.: 33 AF XY: 0.136 AC XY: 10115AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
21115
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
10115
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
1797
AN:
41578
American (AMR)
AF:
AC:
1498
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
650
AN:
3470
East Asian (EAS)
AF:
AC:
29
AN:
5188
South Asian (SAS)
AF:
AC:
676
AN:
4828
European-Finnish (FIN)
AF:
AC:
2069
AN:
10592
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13972
AN:
68014
Other (OTH)
AF:
AC:
266
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
920
1840
2761
3681
4601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
230
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.